This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format in EST Time Zone

Dominic Hildebrand
Senior Scientist, Analytical Development & Clinical Quality Control, Product Supply Biotech at Bayer


Dr. Dominic Hildebrand, earned his Ph.D. in Molecular Medicine in Tübingen, Germany, and thereafter started at Bayer as a project manager for antibody lead discovery and lead optimization in 2013. He subsequently joined the Biological Development unit as a labhead for analytical development and clinical quality control in 2017. Since 2019 he is responsible for coordinating Bayer’s analytical platform approach for cellular therapeutics

Agenda Sessions

  • BioPhorum Session: Applying a matrix approach for potency assay development for in vivo and ex vivo gene therapies.